10.38
price up icon2.27%   0.23
after-market Handel nachbörslich: 10.38
loading
Schlusskurs vom Vortag:
$10.15
Offen:
$9.98
24-Stunden-Volumen:
118.75K
Relative Volume:
0.60
Marktkapitalisierung:
$359.12M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+5.49%
1M Leistung:
+6.79%
6M Leistung:
-58.01%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$9.81
$10.64
1-Wochen-Bereich:
Value
$9.01
$10.64
52-Wochen-Spanne:
Value
$7.13
$29.74

Rapport Therapeutics Inc Stock (RAPP) Company Profile

Name
Firmenname
Rapport Therapeutics Inc
Name
Telefon
857-321-8020
Name
Adresse
1325 BOYLSTON STREET, BOSTON
Name
Mitarbeiter
69
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
RAPP's Discussions on Twitter

Vergleichen Sie RAPP mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
RAPP
Rapport Therapeutics Inc
10.38 359.12M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.52 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.49 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
595.70 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
232.75 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
229.22 26.16B 3.81B -644.79M -669.77M -6.24

Rapport Therapeutics Inc Stock (RAPP) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-08 Eingeleitet Citizens JMP Mkt Outperform
2024-07-02 Eingeleitet Jefferies Buy
2024-07-02 Eingeleitet Stifel Buy
2024-07-02 Eingeleitet TD Cowen Buy

Rapport Therapeutics Inc Aktie (RAPP) Neueste Nachrichten

pulisher
Apr 17, 2025

Rapport therapeutics chief scientific officer sells $81,310 of stock - Investing.com Australia

Apr 17, 2025
pulisher
Apr 16, 2025

Rapport therapeutics chief scientific officer sells $81,310 of stock By Investing.com - Investing.com South Africa

Apr 16, 2025
pulisher
Apr 13, 2025

KLP Kapitalforvaltning AS Purchases Shares of 1,900 Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Apr 13, 2025
pulisher
Apr 13, 2025

48,452 Shares in Rapport Therapeutics (NASDAQ:RAPP) Acquired by Norges Bank - Defense World

Apr 13, 2025
pulisher
Apr 12, 2025

Comparing Rapport Therapeutics (RAPP) & The Competition - Defense World

Apr 12, 2025
pulisher
Apr 10, 2025

Rapport Therapeutics (NASDAQ:RAPP) Coverage Initiated at JMP Securities - Defense World

Apr 10, 2025
pulisher
Apr 08, 2025

JMP Securities Initiates Coverage of Rapport Therapeutics (RAPP) with Market Outperform Recommendation - Nasdaq

Apr 08, 2025
pulisher
Apr 08, 2025

Citizens JMP sets $28 target for Rapport Therapeutics stock By Investing.com - Investing.com Canada

Apr 08, 2025
pulisher
Apr 05, 2025

(RAPP) Investment Analysis - news.stocktradersdaily.com

Apr 05, 2025
pulisher
Apr 02, 2025

nCino Posts Weak Earnings, Joins Tesla And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga

Apr 02, 2025
pulisher
Mar 31, 2025

Rapport Therapeutics: Too Early To Be Interesting (NASDAQ:RAPP) - Seeking Alpha

Mar 31, 2025
pulisher
Mar 31, 2025

Swiss National Bank Purchases New Stake in Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Mar 31, 2025
pulisher
Mar 27, 2025

Analyzing Neurogene (NASDAQ:NGNE) & Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Mar 27, 2025
pulisher
Mar 26, 2025

Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga

Mar 26, 2025
pulisher
Mar 26, 2025

(RAPP) Long Term Investment Analysis - news.stocktradersdaily.com

Mar 26, 2025
pulisher
Mar 26, 2025

Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga

Mar 26, 2025
pulisher
Mar 23, 2025

Vanda Pharmaceuticals (NASDAQ:VNDA) and Rapport Therapeutics (NASDAQ:RAPP) Financial Contrast - Defense World

Mar 23, 2025
pulisher
Mar 21, 2025

Rapport Therapeutics to present data at 2025 AAN meeting - TipRanks

Mar 21, 2025
pulisher
Mar 21, 2025

Rapport Therapeutics to Present Data at the 2025 American Academy of Neurology Annual Meeting - GlobeNewswire

Mar 21, 2025
pulisher
Mar 21, 2025

Rapport Therapeutics to Present Data at the 2025 American Academy of Neurology Annual Meeting - GlobeNewswire Inc.

Mar 21, 2025
pulisher
Mar 15, 2025

Several Insiders Invested In Rapport Therapeutics Flagging Positive News - simplywall.st

Mar 15, 2025
pulisher
Mar 15, 2025

Positive Signs As Multiple Insiders Buy Rapport Therapeutics Stock - Yahoo

Mar 15, 2025
pulisher
Mar 15, 2025

Insider Buying: Rapport Therapeutics Chief Financial Officer Bought US$101k Of Shares - Yahoo Finance

Mar 15, 2025
pulisher
Mar 14, 2025

Rapport Therapeutics director Wendy Young acquires $61,249 in stock By Investing.com - Investing.com India

Mar 14, 2025
pulisher
Mar 13, 2025

Rapport Therapeutics CFO Troy Ignelzi buys $100,988 in stock - Investing.com

Mar 13, 2025
pulisher
Mar 13, 2025

Rapport Therapeutics CFO Troy Ignelzi buys $100,988 in stock By Investing.com - Investing.com India

Mar 13, 2025
pulisher
Mar 13, 2025

Rapport Therapeutics Executives Acquire Shares - TradingView

Mar 13, 2025
pulisher
Mar 13, 2025

Rapport Therapeutics director Wendy Young acquires $61,249 in stock - Investing.com

Mar 13, 2025
pulisher
Mar 11, 2025

Rapport Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - The Manila Times

Mar 11, 2025
pulisher
Mar 11, 2025

Rapport Therapeutics Reports Q4 Net Loss Of $19.98 Mln - Nasdaq

Mar 11, 2025
pulisher
Mar 11, 2025

Rapport Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 11, 2025
pulisher
Mar 11, 2025

Rapport Therapeutics reports Q4 EPS (57c) vs. ($8.01) last year - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

Rapport Therapeutics Inc Q4 Net Loss $20.0 Million -March 11, 2025 at 07:20 am EDT - Marketscreener.com

Mar 11, 2025
pulisher
Mar 11, 2025

Rhumbline Advisers Has $182,000 Stock Position in Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Mar 11, 2025
pulisher
Mar 07, 2025

New York State Common Retirement Fund Acquires New Position in Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Mar 07, 2025
pulisher
Mar 05, 2025

(RAPP) On The My Stocks Page - Stock Traders Daily

Mar 05, 2025
pulisher
Mar 04, 2025

Head of R&D Robert Lenz to leave Neumora - BioCentury

Mar 04, 2025
pulisher
Mar 03, 2025

Rapport Therapeutics appoints new chief medical officer By Investing.com - Investing.com Canada

Mar 03, 2025
pulisher
Mar 03, 2025

Rapport Therapeutics, Inc. Announces Appointment of Jeffrey Sevigny as Chief Medical Officer - Marketscreener.com

Mar 03, 2025
pulisher
Mar 03, 2025

Rapport Therapeutics Announces Appointment of Dr. Jeffrey Sevigny as Chief Medical Officer to Drive Clinical Strategy and Precision Medicine Development - The Manila Times

Mar 03, 2025
pulisher
Mar 03, 2025

Rapport Therapeutics appoints new chief medical officer - Investing.com

Mar 03, 2025
pulisher
Mar 03, 2025

Rapport Therapeutics Announces Appointment of Dr. Jeffrey - GlobeNewswire

Mar 03, 2025
pulisher
Feb 24, 2025

Rapport Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times

Feb 24, 2025
pulisher
Feb 22, 2025

Rapport Therapeutics (RAPP) Expected to Announce Earnings on Thursday - Defense World

Feb 22, 2025
pulisher
Feb 20, 2025

Rapport Therapeutics (NASDAQ:RAPP) Stock Price Down 8.5%Here's What Happened - MarketBeat

Feb 20, 2025
pulisher
Feb 13, 2025

Rapport Therapeutics (NASDAQ:RAPP) Shares Gap UpHere's Why - MarketBeat

Feb 13, 2025
pulisher
Feb 12, 2025

How To Trade (RAPP) - Stock Traders Daily

Feb 12, 2025
pulisher
Feb 11, 2025

Rapport Therapeutics (NASDAQ:RAPP) Shares Down 5.6%What's Next? - MarketBeat

Feb 11, 2025
pulisher
Feb 10, 2025

Jennison Associates LLC Acquires Shares of 62,287 Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat

Feb 10, 2025

Finanzdaten der Rapport Therapeutics Inc-Aktie (RAPP)

Es liegen keine Finanzdaten für Rapport Therapeutics Inc (RAPP) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.07
price up icon 0.15%
$69.51
price down icon 4.32%
$32.19
price down icon 1.26%
$25.22
price up icon 2.48%
$101.81
price up icon 3.09%
biotechnology ONC
$229.22
price down icon 0.76%
Kapitalisierung:     |  Volumen (24h):